₨ NPR
AASMA-XR-300MG
AASMA-XR 300MG is an extended-release bronchodilator tablet containing Theophylline, which is used for the management of chronic asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). The extended-release formulation provides long-lasting symptom control by relaxing the airway muscles and improving airflow to the lungs.
₨17.50
Ask about productDescription
AASMA-XR 300MG is an extended-release bronchodilator tablet containing Theophylline, which is used for the management of chronic asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). The extended-release formulation provides long-lasting symptom control by relaxing the airway muscles and improving airflow to the lungs.
Indications:
- Chronic Asthma
- Bronchial Asthma
- COPD (Chronic Obstructive Pulmonary Disease)
- Emphysema
- Chronic Bronchitis
Benefits:
- Provides long-acting bronchodilation
- Helps control nighttime asthma symptoms
- Reduces the frequency and severity of asthma attacks
- Enhances respiratory function
- Convenient twice-daily or once-daily dosing (as prescribed)
Dosage & Administration:
Dosage should be individualized based on age, weight, and clinical condition.
Typical Adult Dose: One tablet once or twice daily as directed by a physician.
Swallow whole; do not crush or chew.
Storage Instructions:
- Store below 25°C in a dry place
- Protect from light and moisture
- Keep out of reach of children
Warnings & Precautions:
- Use under medical supervision only
- Monitor blood theophylline levels in long-term use
- Use with caution in patients with liver disease, heart failure, or seizure disorders
- Avoid in patients with known hypersensitivity to xanthine derivatives
- Avoid caffeine and other stimulants during treatment
Side Effects May Include:
- Nausea or vomiting
- Headache
- Insomnia
- Palpitations
- Restlessness
Additional information
| form | Oral Tablets |
|---|
Reviews
There are no reviews yet.